These days, clinical trial sponsors are being asked to provide empirical evidence to many stakeholders with diverse needs and to do so efficiently. By taking a holistic view of post-approval evidence needs, it is possible to address many stakeholders' needs, thereby minimizing expense while increasing the likelihood of getting data that are fit for a variety of purposes.